Health & Fitness
Health and Fitness
Health and Fitness
Wed, February 8, 2012Tue, February 7, 2012Mon, February 6, 2012Sun, February 5, 2012Sat, February 4, 2012Fri, February 3, 2012Thu, February 2, 2012Wed, February 1, 2012Tue, January 31, 2012Mon, January 30, 2012Sat, January 28, 2012Fri, January 27, 2012Thu, January 26, 2012Wed, January 25, 2012AMRI CFO to Present at UBS 22nd Annual Global Healthcare Services Conference
Published in Health and Fitness on Wednesday, February 1st 2012 at 5:10 GMT by Market Wire
AMRI CFO to Present at UBS 22nd Annual Global Healthcare Services Conference -- ALBANY, N.Y., Feb. 1, 2012 /PRNewswire/ --
AMRI CFO to Present at UBS 22nd Annual Global Healthcare Services Conference
ALBANY, N.Y., Feb. 1, 2012 /PRNewswire/ -- AMRI (NASDAQ: [ AMRI ]) announced today that AMRI Senior Vice President, Administration and Chief Financial Officer Mark T. Frost will present at the UBS 22nd Annual Global Healthcare Services Conference on Wednesday, February 8, 2012 at 11:00 a.m. ET.
An audio webcast of the corporate presentation will be available to investors and interested parties by accessing the company's website at [ www.amriglobal.com ]. A replay of the webcast will be available immediately after the live webcast through May 8, 2012.
Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization with more than twenty years experience providing customers fully integrated drug discovery, development, and manufacturing services. AMRI supplies a broad range of services and technologies that support the discovery and development of pharmaceutical products and the manufacturing of API and drug product for existing and experimental new drugs. With locations in the United States, Europe, and Asia, AMRI maintains geographic proximity and flexible cost models. AMRI has also historically leveraged its drug-discovery expertise to execute on several internal drug discovery programs, which have progressed to the development candidate stage and in some cases into Phase I clinical development. AMRI has successfully partnered certain programs and is actively seeking to out-license its remaining programs to strategic partners for further development.
SOURCE AMRI
[ Back to top ] RELATED LINKS
[ http://www.amriglobal.com ]
